Data may be out of date. Our scheduled checks are behind: the last successful check of the sources finished 20 Oct 2026, 21:00 UTC (16 days ago), more than 36 hours ago. Checks normally run twice daily, so figures on this page may be out of date. See the service status.
ShortageSignal

← All medicines

Medicine · bench card

Emerade

As of 06 Nov 2026 07:18 UTC. Status is always as stated in the latest recorded notice; the sources do not publish resolution, so nothing on this page says a medicine is back — see methodology.

Latest England safety alertNatPSA/2023/004/MHRA · issued 09 May 2023 (1277 days ago)
Expected backno date stated by the source in the latest recorded notice
Protocolno Serious Shortage Protocol matched to this name on the NHSBSA register
ScotlandMSAN(2019)24 issued 02 Dec 2019 — NHS Scotland's own notice, matched by name; kept separate from England

Presentations, as stated in the latest recorded notice

No product lines could be read from the latest recorded notice for this medicine, so no presentation-level status is shown. The notice itself is listed in the history below.

Protocol in force

No Serious Shortage Protocol matched to this name is in force on the NHSBSA register. Matching is by name until identifier coding lands.

Named in the source as remaining available

The latest recorded notice names no alternative as remaining available.

Identifiers — Emerade

Also known as
Emerade 150micrograms/0.15ml (1 in 1,000) inj auto-injectors · Emerade 300micrograms/0.3ml (1 in 1,000) inj auto-injectors · Emerade 500micrograms/0.5ml (1 in 1,000) inj auto-injectors
BNF chemical
Adrenaline 0304030C0 — matched on a brand name
Class
Allergic emergencies · Antihistamines, hyposensitisation and allergic emergencies · Respiratory System
SNOMED codes
23415411000001104, 23415811000001102, 23420111000001107
Suppliers named in the NHSBSA dataset
Bausch & Lomb UK Ltd (from the dataset, not from the notices)
Also recorded under
Jext (brand) — same BNF chemical; separate pages, separate counts

BNF chemical and SNOMED identifiers from NHSBSA Prescription Cost Analysis (Open Government Licence), matched by name (presentation name), confidence 0.90 — grouping under review where marked Release Jul 2026.

BNF SNOMED mapping, NHSBSA Copyright 2026; Prescription Cost Analysis (PCA) Monthly Administrative Data, NHSBSA Copyright 2026. This information is licenced under the terms of the Open Government Licence.

History

One supply notification on record, 09 May 2023. We record when a shortage is declared, not when stock returns — the source doesn't publish that. An update sharing a reference counts as one episode.

Also recorded under

No other name appears in this medicine's notice titles. Grouping is by the head name in each title; brand and generic names may still sit on separate pages until identifier coding refines it — see the A–Z.

Scotland — separate record

NHS Scotland issues its own Medicine Supply Alert Notices. These match this medicine's name; they are shown beside, never added to, the England record.

Last checked
20 Oct 2026 — sources are checked twice daily by scheduled jobs, not continuously
Last source change
19 Oct 2026
Latest notice captured
11 Jun 2023
Sources
Latest notice post ↗https://cpe.org.uk/our-news/national-patient-safety-alert-class-1-medicines-recall-emerade-500-micrograms-and-emerade-300-micrograms-auto-injectors · methodology · corrections log

Re-expressed facts with links to the source documents; roles are inferred from phrasing and flagged; fuzzy dates stay fuzzy. Not an official NHS or DHSC service and not clinical advice — in a shortage, follow the guidance issued to your pharmacy or prescriber. Absence of a record is never availability.